Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.

Taş S., Antal A., Durusoy A. F., Yanartaş M., Yıldız K., Olgun Yıldızeli Ş., ...Daha Fazla

Anatolian journal of cardiology, cilt.26, sa.5, ss.394-400, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5152/anatoljcardiol.2021.1138
  • Dergi Adı: Anatolian journal of cardiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.394-400
  • Anahtar Kelimeler: Antiphospholipid syndrome, chronic thromboembolic pulmonary hypertension, pulmonary endarterectomy, outcome, SYSTEMIC-LUPUS-ERYTHEMATOSUS, INTERNATIONAL CONSENSUS STATEMENT, CLASSIFICATION CRITERIA, ANTIBODIES, ANTICOAGULANT, MANAGEMENT, THROMBOSIS, DIAGNOSIS
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Antiphospholipid syndrome is an autoimmune disease characterized by the occurrence of venous and/or arterial thrombosis. Chronic thromboembolism is one of the known established pathogenesis of pulmonary hypertension, known as chronic thromboembolic pulmonary hypertension. Pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension. The aim of this study is to evaluate the efficacy and risk of pulmonary endarterectomy in patients with anti-phospholipid syndrome-associated chronic thromboembolic pulmonary hypertension.